Latest News

Genetic evidence that new therapies targeting Parkinson's disease may cause harm

Researchers have completed a small study that shows genetic and clinical evidence that therapies targeting the expression of alpha-synuclein -- a gene whose function is involved in the development and progression of Parkinson?s disease -- may accelerate disease progression and increase the risk of physical incapacitation and dementia. If replicated, the findings will have profound implications for therapies under development for Parkinson?s disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Off-season doesn't allow brain to recover from football hits, study says

  • Rapid whole-brain imaging with single cell resolution

  • Trisomy 21: How an extra little chromosome throws entire genome off balance

  • Anti-seizure drug may reduce alcohol consumption, study shows

  • The ilk of human kindness: Older women with gumption score high on compassion

  • Our relationship with God changes when faced with potential romantic rejection

  • Sporting latest tech toy can make you seem more like a leader

  • Progressive neurodegenerative disorder linked to R-loop formation

  • New pain relief targets discovered by researchers

  • Better way to deal with bad memories suggested

  •